INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Pooled results from many studies on one question.

183 studies · page 2 of 8

2021 / Systematic review and meta-analysis

Obesity, smoking, older age, male sex, and various comorbidities were linked to increased risk of COVID-19 mortality in hospitalized patients.

A systematic review and meta-analysis of 42 studies with 423,117 patients assessed clinical risk factors associated with COVID-19 mortality. The pooled prevalence of mortality among hospitalized patients was 17.62% (95% CI 14.26-21.57%). Increased mortality risk was linked to older age (pOR 2.61, pHR 1.31), male sex (pOR 1.45, pHR 1.24), and current smoking status (pOR 1.42). Obesity, acute kidney injury, chronic obstructive pulmonary disease, cardiovascular disease, diabetes, hypertension, cancer, and increased D-dimer were also reported as clinical risk factors for fatal outcomes.

Shows an association, not proof of cause and effect.

Dessie ZG, Zewotir T BMC Infect Dis, 2021. PMID 34418980

2020 / Meta-analysis of prospective cohort studies

Potato intake was not significantly associated with all-cause or cancer mortality in cohorts.

A meta-analysis evaluated 20 prospective cohort studies assessing potato consumption and mortality risk. No significant associations were observed for all-cause mortality (0.90, 95% CI: 0.80 to 1.02, p = 0.096; 25,208 cases) or cancer mortality (1.09, 95% CI: 0.96 to 1.24, P = 0.204; 4,877 cases). Among three studies examining cardiovascular mortality (2,366 cases), two found no significant relationship.

Shows an association, not proof of cause and effect.

Darooghegi Mofrad M, Milajerdi A, Sheikhi A, et al. Crit Rev Food Sci Nutr, 2020. PMID 30638040

2020 / Systematic review and meta-analysis of observational studies

Physical activity levels well above recommended amounts were linked to lower risks of all-cause and cardiovascular disease mortality.

A systematic review and meta-analysis of 48 studies examined the link between high amounts of physical activity and mortality in the general population. Compared with the recommended level of 750 MET min/week, mortality risk was lower at physical activity levels exceeding recommendations up to at least 5000 MET min/week for all-cause mortality (HR=0.86, 95% CI 0.78 to 0.94) and CVD mortality (HR=0.73, 95% CI 0.56 to 0.95). There was no threshold observed beyond which lifespan was compromised. Limitations reported include the observational nature of the included studies and inaccurate estimations of physical activity amounts.

Shows an association, not proof of cause and effect.

Blond K, Brinkløv CF, Ried-Larsen M, et al. Br J Sports Med, 2020. PMID 31406017

2020 / Systematic review and meta-analysis of observational studies

Adherence to 2007 WCRF/AICR lifestyle recommendations was linked to lower risks of breast, colorectal, and lung cancers, as well as reduced mortality.

A systematic review and meta-analysis evaluated 38 observational studies examining adherence to the 2007 WCRF/AICR lifestyle recommendations. Each 1-point increase in the score was associated with lower risk of breast cancer (RR = 0.90, 95% CI: 0.87-0.93, n = 11), colorectal cancer (RR = 0.86, 95% CI: 0.82-0.89, n = 10), and lung cancer (RR = 0.93, 95% CI: 0.89-0.96, n = 2). No statistically significant associations were found for prostate or pancreatic cancers. Adherence was also associated with lower overall mortality (RR = 0.90, 95% CI: 0.84-0.96, n = 3) and cancer-specific mortality (RR = 0.91, 95% CI: 0.89-0.92, n = 3) in healthy populations, and higher survival in cancer patients (n = 2).

Shows an association, not proof of cause and effect.

Solans M, Chan DSM, Mitrou P, et al. Ann Oncol, 2020. PMID 32067678

2020 / Cohort study and meta-analysis of prospective cohort studies

Pooled prospective studies found no significant association between potato consumption and total, cardiovascular, or stroke mortality.

In an NHANES cohort of 24,856 participants (mean follow-up 6.4 years, 3,433 deaths), higher potato consumption was initially associated with higher risks of total (42%), CVD (65%), cerebrovascular (26%), and cancer (52%) mortality (p < 0.001), but these associations disappeared after adjustment for confounding factors. In a pooled meta-analysis of prospective studies (98,569 participants), potato intake showed no significant association with total (RR = 1.25, 95% CI 0.98-1.60), CVD (RR = 0.99, 95% CI 0.90-1.08), or stroke mortality (RR = 0.94, 95% CI 0.85-1.03). However, individuals with higher potato intake displayed less favorable cardiometabolic profiles, including higher waist circumference (97.2 vs. 99.5 cm) and worse blood pressure, triglycerides, HDL-C, and TG/HDL-C ratio (all p < 0.001).

Shows an association, not proof of cause and effect.

Mazidi M, Katsiki N, Mikhailidis DP, et al. Arch Med Sci, 2020. PMID 32190135

2020 / Systematic review and meta-analysis of prospective studies

Higher consumption of total and soluble fiber was linked to a lower risk of breast cancer in a meta-analysis of prospective studies.

Researchers conducted a meta-analysis of prospective studies through July 2019 to evaluate total and specific fiber consumption and breast cancer risk. Comparing the highest versus lowest intake categories, total fiber was associated with an 8% lower risk of breast cancer (pooled RR 0.92; 95% CI, 0.88-0.95; I2 = 12.6%). Soluble fiber intake was significantly inversely associated with risk (pooled RR 0.90; 95% CI, 0.84-0.96), while insoluble fiber showed a suggestive inverse association (pooled RR 0.93; 95% CI, 0.86-1.00). Total fiber was linked to lower risk in both premenopausal (RR 0.82; 95% CI, 0.67-0.99) and postmenopausal (RR 0.91; 95% CI, 0.88-0.95) breast cancers.

Shows an association, not proof of cause and effect.

Farvid MS, Spence ND, Holmes MD, et al. Cancer, 2020. PMID 32249416

2020 / Meta-analysis of prospective cohorts

Higher plant protein intake is linked to lower all-cause mortality in cohorts.

A meta-analysis of 12 cohort studies examined dietary protein intake and mortality. Higher plant protein intake was associated with lower all-cause mortality (RR 0.92, 95% CI: 0.88 to 0.96 for highest versus lowest; RR 0.97, 95% CI: 0.94 to 0.99 per 3% increment) and may be associated with reduced cardiovascular mortality (RR 0.90, 95% CI: 0.80 to 1.01). Higher animal protein intake was possibly linked to greater cardiovascular death risk (RR 1.11, 95% CI: 1.01 to 1.22). Total protein showed no clear association with mortality.

Shows an association, not proof of cause and effect.

Qi XX, Shen P Nutr Metab Cardiovasc Dis, 2020. PMID 32451273

2020 / Meta-analysis of 18 observational studies (5 cohorts, 13 case-control)

Higher dietary soy intake was linked to a lower risk of breast cancer regardless of estrogen receptor status, especially in premenopausal women.

Researchers meta-analyzed data from 18 observational studies (5 cohorts and 13 case-control) searched through December 2019 to evaluate the link between soy intake and breast cancer risk by estrogen receptor status. Comparing highest versus lowest soy food intake, soy was inversely associated with breast cancer risk overall (OR 0.88, 95% CI 0.84-0.92, P < 0.001, I2 = 76.1%). The inverse link was stronger in premenopausal women (OR 0.79, 95% CI 0.71-0.87, P < 0.001) and was observed in both ER-negative cases (OR 0.71, 95% CI 0.57-0.90, P = 0.013) and ER-positive cases (OR 0.87, 95% CI 0.79-0.96, P = 0.008).

Shows an association, not proof of cause and effect.

Okekunle AP, Gao J, Wu X, et al. Heliyon, 2020. PMID 32642579

2020 / Meta-analysis of prospective cohort studies

Higher flavonoid intake was linked to lower risks of all-cause and cardiovascular disease mortality in a meta-analysis of cohort studies.

A systematic review and meta-analysis of 16 prospective cohort studies examined the relationship between flavonoid intake and mortality across 462,194 participants followed for 4.8 to 28 years. Flavonoid consumption was inversely and significantly associated with total mortality (RR: 0.87, 95% CI: 0.77-0.99) and cardiovascular disease mortality (RR: 0.85, 95% CI: 0.75-0.97). No significant association was found with cancer mortality risk (RR: 0.86, 95% CI: 0.65-1.14).

Shows an association, not proof of cause and effect.

Mazidi M, Katsiki N, Banach M Nutrients, 2020. PMID 32781562

2020 / Systematic review and meta-analysis of observational studies

Current alcohol intake was linked to a lower risk of follicular lymphoma, while BMI and smoking showed no significant associations.

A systematic review and meta-analysis evaluated 24 cohort and 10 case-control studies assessing lifestyle factors and follicular lymphoma (FL) risk. Current alcohol intake was inversely associated with FL risk (meta-RR 0.87, 95% CI 0.81-0.94; p-trend = 0.008 per 5 drinks/week increase). Current smoking (meta-RR 1.11, 95% CI 0.92-1.35) and adult BMI factors—including being overweight (meta-RR 0.99, 95% CI 0.92-1.07) or obese (meta-RR 1.08, 95% CI 0.99-1.17)—showed no significant associations. Hair dye use before 1980 was positively associated with FL risk (meta-RR 1.66, 95% CI 1.22-2.25), but no association was observed after 1980.

Shows an association, not proof of cause and effect.

Odutola MK, Nnakelu E, Giles GG, et al. Cancer Causes Control, 2020. PMID 32851495

2020 / Systematic review and meta-analysis of RCTs

Vitamin D supplementation reduced adverse colorectal cancer outcomes by 30% in a meta-analysis of randomized controlled trials.

A systematic review and random-effects meta-analysis evaluated the effect of vitamin D supplementation on colorectal cancer (CRC) survival outcomes across RCTs. Across five included trials (n = 815), supplementation was associated with a 30% reduction in adverse CRC outcomes (HR = 0.70; 95% CI: 0.48-0.93). A beneficial effect on progression-free survival was observed in trials of patients with CRC at the outset (HR = 0.65; 95% CI: 0.36-0.94), along with a suggestive effect on CRC-specific survival in incident cases from population trials (HR = 0.76; 95% CI: 0.39-1.13). The authors noted trials varied in inclusion criteria, intervention dose, and outcomes.

Vaughan-Shaw PG, Buijs LF, Blackmur JP, et al. Br J Cancer, 2020. PMID 32929196

2020 / Systematic review and meta-analysis of randomized controlled trials

Yoga significantly improved fatigue and quality of life in women with breast cancer compared to non-physical activity, but not compared to physical activity.

A systematic review and meta-analysis of 24 randomized controlled trials evaluated the effects of yoga interventions on cancer-related fatigue (CRF) and quality of life (QOL) in women with breast cancer. Compared to non-physical activity comparators, yoga demonstrated statistically significant improvements in CRF (SMD -0.30 [-0.51; -0.08]) and QOL (SMD -0.27 [-0.46; -0.07]). However, when compared to other physical activity interventions, yoga did not show statistically significant improvements in CRF (SMD -0.17 [-0.50; 0.17]) or QOL (SMD 0.04 [-0.22; +0.31]).

O'Neill M, Samaroo D, Lopez C, et al. Integr Cancer Ther, 2020. PMID 33073636

2019 / Systematic review and meta-analysis of observational studies

French fries intake was linked to higher risk of diabetes and hypertension.

Researchers analyzed 28 reports examining potato intake and chronic disease risks. Total potato consumption showed no associations with all-cause mortality (RR 0.88, 95% CI 0.69-1.12), coronary heart disease, stroke, or colorectal cancer per 150 g/day increase. Conversely, each 150 g/day increase in French fries intake was linked to higher risks of type 2 diabetes (RR 1.66, 95% CI 1.43-1.94) and hypertension (RR 1.37, 95% CI 1.15-1.63), based on mostly low- to moderate-certainty evidence.

Shows an association, not proof of cause and effect.

Schwingshackl L, Schwedhelm C, Hoffmann G, et al. Eur J Nutr, 2019. PMID 29987352

2019 / Systematic review and meta-analysis of observational studies

A more pro-inflammatory diet, as measured by higher Dietary Inflammatory Index scores, was linked to an increased risk of prostate cancer.

A meta-analysis of five case-control studies and one cohort study was conducted to evaluate the link between the Dietary Inflammatory Index (DII) and prostate cancer risk. The adjusted pooled relative risk of prostate cancer comparing the highest to the lowest DII categories was 1.74 (95% CI: 1.24-2.43). When evaluated as a continuous variable, the risk of prostate cancer was 9% higher for each one-point increase in the DII score.

Shows an association, not proof of cause and effect.

Mohseni R, Abbasi S, Mohseni F, et al. Nutr Cancer, 2019. PMID 30273060

2019 / Systematic review and meta-analysis of clinical trials

Vitamin D supplementation did not significantly affect PSA change, PSA response, or mortality in controlled trials of prostate cancer patients.

A systematic review and meta-analysis evaluated 22 clinical trials (16 before-after studies and 6 randomized controlled trials) investigating vitamin D supplementation in patients with prostate cancer. In controlled clinical trials, vitamin D supplementation did not significantly differ from placebo for PSA change from baseline (WMD=-1.66 ng/ml, 95% CI: -0.69 to 0.36, p=0.543), PSA response proportion (RP=1.18, 95% CI: 0.97 to 1.45, p=0.104), or mortality (RR=1.05, 95% CI: 0.81 to 1.36, p=0.713). In single-arm trials, 19% of enrolled patients achieved at least a 50% reduction in PSA by the end of treatment (95% CI: 7% to 31%, p=0.002). The authors concluded that prostate cancer patients do not appear to benefit from high-dose vitamin D supplementation and it should not be recommended for treatment.

Shahvazi S, Soltani S, Ahmadi SM, et al. Horm Metab Res, 2019. PMID 30522147

2019 / Systematic reviews and meta-analyses of prospective cohorts and trials

Higher intake of dietary fiber was linked to lower mortality and disease incidence, and reduced bodyweight and blood pressure in trials.

Researchers analyzed 185 prospective studies and 58 clinical trials examining carbohydrate quality markers. Observational data suggested a 15-30% decrease in all-cause and cardiovascular mortality, coronary heart disease, stroke, type 2 diabetes, and colorectal cancer when comparing highest versus lowest dietary fiber consumers. Clinical trials showed significantly lower bodyweight, systolic blood pressure, and total cholesterol with higher dietary fiber intakes. Similar findings were observed for whole grains, whereas evidence for low glycemic index or load showed smaller or no risk reductions.

Reynolds A, Mann J, Cummings J, et al. Lancet, 2019. PMID 30638909

2019 / Meta-analysis of cohort studies

Physical activity was linked to a lower risk of breast cancer in a meta-analysis of 38 cohort studies.

A systematic review and meta-analysis of 38 cohort studies examined the relationship between physical activity (PA) and breast cancer risk across 68,416 cases. The overall relative risk (ORR) for breast cancer was 0.87 (95% CI 0.84-0.90). In subgroup analysis, the ORR was 0.83 (95% CI 0.79-0.87) for premenopausal women and 0.91 (95% CI 0.85-0.97) for postmenopausal women. Breast cancer risk decreased by 3% (ORR 0.97, 95% CI 0.95-0.99) for every 10 MET-hours/week increment in recreational PA and by 2% (ORR 0.98, 95% CI 0.97-0.99) per 10 MET-hours/week increment in total PA.

Shows an association, not proof of cause and effect.

Chen X, Wang Q, Zhang Y, et al. Value Health, 2019. PMID 30661625

2019 / Umbrella review of observational studies

Fruit and vegetable intake shows probable evidence for cardiovascular disease protection in reviews.

An umbrella review examined quantitative syntheses of observational studies linking produce intake with health outcomes. Probable evidence was observed for cardiovascular protection, while possible evidence indicated lower risks of colon malignancies, depressive disorders, and pancreatic ailments for fruits. For vegetable consumption, possible evidence supported lower risks of stroke, hip fractures, colorectal malignancies, depression, and pancreatic conditions, though geographical location and sex were potential confounding factors.

Shows an association, not proof of cause and effect.

Angelino D, Godos J, Ghelfi F, et al. Int J Food Sci Nutr, 2019. PMID 30764679

2019 / Meta-analysis of randomized controlled trials

Vitamin D supplementation significantly reduced total cancer mortality but did not affect total cancer incidence in a meta-analysis of RCTs.

A meta-analysis of randomized controlled trials examined the effects of vitamin D supplementation on total cancer incidence and mortality. For total cancer incidence (10 trials, 6,537 cases), supplementation had no significant effect (RR 0.98; 95% CI, 0.93-1.03; P = 0.42), even when attained 25(OH)D levels exceeded 100 nmol/l. For total cancer mortality (5 trials, 1,591 deaths), vitamin D supplementation significantly reduced risk (RR 0.87; 95% CI, 0.79-0.96; P = 0.005), an effect largely driven by trials using daily dosing rather than infrequent bolus dosing.

Keum N, Lee DH, Greenwood DC, et al. Ann Oncol, 2019. PMID 30796437

2019 / Meta-analysis of fecal shotgun metagenomic studies

A meta-analysis of fecal metagenomes identified a core set of 29 microbial species significantly enriched in colorectal cancer.

Researchers conducted a meta-analysis of eight geographically and technically diverse fecal shotgun metagenomic studies of colorectal cancer (CRC, n = 768), controlling for several confounders. They identified a core set of 29 species significantly enriched in CRC metagenomes (FDR < 1 x 10^-5) and found that training across multiple studies improved detection accuracy and specificity. Functional analyses revealed enriched protein and mucin catabolism genes and depleted carbohydrate degradation genes. Inferred elevated production of secondary bile acids suggested a metabolic link between CRC-associated gut microbes and a fat- and meat-rich diet.

Shows an association, not proof of cause and effect.

Wirbel J, Pyl PT, Kartal E, et al. Nat Med, 2019. PMID 30936547

2019 / Prospective cohort study and meta-analysis of prospective cohort studies

Lower carbohydrate diets were linked to higher risks of overall, cardiovascular, and cancer mortality.

Researchers examined the link between low-carbohydrate diet (LCD) scores and mortality using NHANES (1999-2010) data and a pooled analysis of nine prospective cohort studies. In NHANES (24,825 participants), those in the lowest carbohydrate quartile had the highest risk of overall (32%), CVD (50%), cerebrovascular (51%), and cancer (36%) mortality compared to the highest carbohydrate intake quartile. In the pooled analysis of nine cohorts (462,934 participants), LCD was associated with higher overall (RR 1.22, 95% CI 1.06-1.39), CVD (RR 1.13, 95% CI 1.02-1.24), and cancer mortality (RR 1.08, 95% CI 1.01-1.14). The authors noted that causality cannot be proven and residual bias cannot be ruled out.

Shows an association, not proof of cause and effect.

Mazidi M, Katsiki N, Mikhailidis DP, et al. Eur Heart J, 2019. PMID 31004146

2019 / Systematic review of clinical studies

Clinical studies link mushroom-derived lentinan to benefits during conventional cancer therapy.

A systematic review evaluated 135 clinical studies from China comprising 9,474 cancer treatment cases involving the shiitake polysaccharide lentinan. Most cases involved lung (3,469), gastric (3,039), or colorectal (1,646) malignancies. Across evaluated reports, lentinan use was linked to better quality of life and greater efficacy of concurrent chemotherapy or radiation treatment.

Zhang M, Zhang Y, Zhang L, et al. Prog Mol Biol Transl Sci, 2019. PMID 31030752

2019 / Systematic review of systematic reviews, meta-analyses, and pooled analyses

Higher physical activity was linked to reduced risk of multiple cancers and decreased mortality among individuals diagnosed with breast, colorectal, or prostate cancer.

Researchers conducted a systematic review of meta-analyses, systematic reviews, and pooled analyses through December 2016, along with an updated search through February 2018, examining physical activity and cancer outcomes. Evaluating 45 reports with several million participants, strong evidence linked highest versus lowest physical activity levels to reduced risks of bladder, breast, colon, endometrial, esophageal adenocarcinoma, renal, and gastric cancers, with relative risk reductions of about 10% to 20%. Across 18 reviews, greater physical activity was also linked to decreased all-cause and cancer-specific mortality in patients with breast, colorectal, or prostate cancer, with relative risk reductions up to almost 40% to 50%. The authors noted that more research is needed on less common cancers, dose-response relationships, and underlying mechanisms.

Shows an association, not proof of cause and effect.

McTiernan A, Friedenreich CM, Katzmarzyk PT, et al. Med Sci Sports Exerc, 2019. PMID 31095082

2019 / Systematic review and meta-analysis

Heme iron intake and serum iron are linked to higher breast cancer risk.

A meta-analysis of 23 studies evaluated iron exposure and breast malignancy risk. Comparing extreme categories, heme iron consumption was linked to higher risk (pooled RR 1.12, 95% CI: 1.04-1.22), as were elevated circulating iron levels (RR 1.22, 95% CI: 1.01-1.47). In contrast, food-derived, supplement-based, or combined total intakes exhibited no significant relationships with breast cancer risk.

Chang VC, Cotterchio M, Khoo E BMC Cancer, 2019. PMID 31170936